Focus

Semax.

Available Variants

5 mg 10 mg 30 mg

View lab reports Quality process

Research area: Focus

🛡️

For research purposes only. Not intended for use in humans or animals.

Neuroscience research

About Semax

Semax is studied in the context of neuroscience and cognitive research. Despite its ACTH origin, Semax is not associated with a cortisol effect but rather with increased levels of the growth factor BDNF in the central nervous system.

Research Application

Studied in cognitive and neuroprotective research, based on its described increase in BDNF in the central nervous system. Despite its ACTH origin, no relevant cortisol effect is reported.

Important to know

Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.

Content 5 mg, 10 mg, 30 mg

Form Lyophilized powder

Category Focus

Purity & Identity see lab reports →

Sequence / Structure Heptapeptide (7 amino acids) – Met-Glu-His-Phe-Pro-Gly-Pro, a fragment of ACTH(4–10)

Regulatory Status Developed in 1982; on the Russian List of Vital and Essential Drugs since 2011. Not FDA approved in the US.

Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.

Research Overview

Studies on neuroscience-related peptides are predominantly preclinical.

Gusev EI, et al. Zh Nevrol Psikhiatr. 2018;118(3):61–68. PMID 29798977
Dolotov OV, et al. Brain Res. 2006;1117(1):54–60. PMID 16996037
Medvedeva EV, et al. BMC Genomics. 2014;15:228. PMID 24661604

References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.

Question about Semax?

We reply personally – via email or Telegram.

✉️ Email ✈️ Telegram

← Back to overview